Chromatin Remodeling in Cancer Stemness, Plasticity, and Therapeutic Resistance: Mechanisms and Targeted Strategies
Year: 2026
Type: article
Abstract: Cancer stem cells (CSCs) comprise phenotypically plastic tumor-cell states associated with tumor propagation, recurrence, and resistance to therapy. Their self-renewal, differentiation potential, and phenotypic plasticity are shaped by genetic, transcriptional, metabolic, and epigenetic mechanisms, including ATP-dependent chromatin remodeling. This article reviews recent research on how chromatin remodeling regulates CSC characteristics. It first summarizes current research on how chromatin remodeling profoundly affects core stemness-related transcriptional networks and key signaling pathways through mechanisms such as changes in chromatin accessibility, nucleosome positioning, and histone variant exchange. Furthermore, this article explores how chromatin remodeling endows CSCs with plasticity, enabling them to adapt to microenvironmental stress and leading to therapy resistance. Finally, it analyzes emerging therapeutic strategies targeting specific chromatin remodeling complexes or factors to investigate CSC-associated vulnerabilities and potential approaches to treatment resistance, aiming to provide new theoretical foundations and potential intervention targets for developing more effective precision cancer therapies. Although these regulatory dependencies identify potential therapeutic vulnerabilities across several tumor types, most evidence remains preclinical, and their therapeutic relevance likely depends on tumor lineage, remodeling-complex composition, genomic context, and the extent to which CSC-selective dependencies can be separated from chromatin-remodeling requirements in normal tissues.
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: chromatin remodeling, cancer stem cells, cancer stemness, phenotypic plasticity, treatment resistance, chromatin accessibility, nucleosome positioning, histone variant exchange, transcriptional regulatory networks, tumor microenvironment, precision cancer therapy, therapeutic vulnerabilities
Open Access status: hybrid
OpenAlex ID: W7229797308
